CARDIFF LEXINGTN CORP - CDIX STOCK NEWS

Cardiff Lexington Corporation (CDIX) appoints Matthew Shafer as Chief Financial Officer to drive strategic growth initiatives and uplisting to a major U.S. exchange.

Cardiff Lexington Corporation (CDIX) expands Nova Ortho and Spine with a new 1,645 square foot facility in Port St. Lucie, Florida. Dr. Kevin Fitzgerald, with over 20 years of medical experience, will oversee the location. The company now has ten strategically placed locations in Florida, aiming for significant geographic growth.

Cardiff Lexington Corporation (OTC PINK:CDIX) announced the reduction of its convertible debt balance by paying off two convertible promissory notes, totaling $175,000. The company aims to simplify its capital structure to support long-term growth, with the CEO highlighting this payment as an example of their strategy execution.

Cardiff Lexington Corporation (OTC PINK:CDIX) announced a 9.8% growth in its healthcare division, driving a 3.5% consolidated revenue growth to $3.4 million for the third quarter. The company also reported a significant 83% gross profit margin in the healthcare division, leading to a consolidated gross profit margin of 79.6% for the quarter. Operating income increased by 52% to $2.3 million, and net income surged by 415% to $1.98 million. The nine-month period showed similar positive trends, with a 16.2% growth in the healthcare division and a 5.1% consolidated revenue growth to $9.8 million. The company's deliberate focus on higher margin business and disciplined cost containment has resulted in a 247% increase in net income to $2.8 million. Additionally, the balance sheet highlights a 39% increase in total assets to $18.5 million and a 250% increase in stockholders' equity to $975,351. Cardiff Lexington CEO, Alex Cunningham, expressed confidence in the company's sustainable, profitable results and announced preparations for an early 2024 uplisting to a major exchange, along with plans to simplify the capital structure for long-term growth.

Cardiff Lexington Corporation (OTC Pink:CDIX) reported a 20% increase in total assets, a 12.6% increase in revenue, a 19.3% increase in gross profit, and a 1,220.0% increase in net income for the three months ended June 30, 2023, compared to the same period in 2022. For the six months ended June 30, 2023, the company reported a 5.9% increase in revenue, a 12.7% increase in gross profit, and a 149.3% increase in net income, compared to the same period in 2022. The company also announced a new revolving financing agreement to support operational growth.

Cardiff Lexington Corporation (OTC PINK:CDIX) reported its 3rd quarter financial results for the period ending September 30, 2022. Key highlights include:

• Stockholders' Equity: Increased by 131%, totaling $6.4 million.
• Total Assets: Rose by 43%, reaching $15.9 million.
• Revenue: Grew by 47%, amounting to $9.4 million.
• Gross Margin: Up by 43%, totaling $6 million.
• Net Loss: Decreased by $1.9 million to ($813,054).

Management expressed optimism about moving beyond cash flow survival.

Cardiff Lexington Corporation (OTC PINK:CDIX) reported remarkable financial results for the 2nd quarter ended June 30, 2022. The company achieved a 95% increase in revenue to $6.07 million, compared to $3.11 million for the same period in 2021. Their gross margin also rose by 92% to $3.82 million. Notably, net income reached $61,826, a $3.1 million improvement from last year, while net loss decreased by $4.33 million. CEO Alex Cunningham expressed optimism for continued growth, anticipating strong results for the impending third quarter.

Cardiff Lexington Corporation (OTC PINK:CDIX) reported a significant turnaround in its financial results for the year ended December 31, 2021. Total stockholders' equity soared to $2.78 million from ($8.87 million) in 2020, marking an increase of $11.65 million. Total assets rose by 126% to $11.16 million, while total liabilities dropped by 40% to $8.38 million. Revenue surged 190% to $10.01 million, and gross margin improved 245% to $6.16 million. Although there was a net loss of ($409,707), this represented an 85% decrease in losses compared to the previous year.

Cardiff Lexington Corporation (OTC PINK:CDIX) released its pro forma historical profit and loss statement, incorporating its recent acquisition of Nova Ortho and Spine. The acquisition is expected to drive growth as Cardiff Lexington's Healthcare Division adds resources for revenue generation. In 2020, combined revenue reached $7.6 million, up 43% from 2019. Notably, net cash improved by over $1 million, and stockholders' equity increased by $7.2 million. The company's focus remains on a 'Buy and Build' strategy within healthcare and financial services.